GLG Partners Boosts Exposure to Yongye International (YONG)

Noam Gottesman’s GLG Partners LP has boosted its stake in Yongye International, Inc (NASDAQ:YONG) to 3.5 million shares from approximately 142,000 shares held at the end of 2013. The stake currently amounts to 6.93% of the company’s shares outstanding.

yongyelogo

Yongye International, Inc. (NASDAQ:YONG) is an agricultural nutrient company. It is engaged in research, development, manufacturing and sales of fulvic acid based crop and animal nutrient products. The market cap of this China based company is around $330 million.

Early this month, the company announced that three leading independent proxy firms – Institutional Shareholder Services Inc., Glass Lewis & Co., LLC, and Egan-Jones Proxy Services – have advised the shareholders of Yongye International, Inc. to vote in favor of Full Alliance International Limited’s acquisition offer for $6.69 per share in cash.

Other stakeholders of Yongye International, Inc. include Matthew Halbower’s Pentwater Capital Management, which holds 4.0 million shares, followed by Glenhill Advisors, led by Glenn J. Krevlin, with ownership of 2.1 million shares.

GLG Partners LP is one of the largest alternative asset managers in the world. It delivers absolute return and long-only investment strategies across asset classes, sectors and geographies. Noam Gottesman founded the fund in 1995 as a division of the Lehman Brothers International; however, it broke off as a stand-alone entity in September 2000. The fund’s portfolio value amounts to $1.4 billion and it is headquartered in London.

Some of the largest investments of the fund as at the end of the fourth quarter of 2013 includes Facebook Inc. (NASDAQ:FB), in which GLG Partners owns approximately 743,800 shares worth $40.7 million. The fund also holds 536,000 shares of Discover Financial Services (NYSE:DFS), with a reported value of $43.7 million. The third largest stake of GLG Partners is in Apple Inc. (NASDAQ:AAPL), which amounts to 50,600 shares worth $28.39 million.

Disclosure:none

Recommended Reading:

Michael Zimmerman Is Betting on J.C. Penney Company (JCP), KKR Financial Holdings LLC (KFN) & Others

Free Stock Research Report: Allegion PLC (ALLE)

Brian Sheehy and Iszo Capital’s Top Stock Picks

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!